Chimpanzee as model of human benign prostatic hyperplasia

被引:38
|
作者
Steiner, MS
Couch, RC
Raghow, S
Stauffer, D
机构
[1] Univ Tennessee, Med Ctr, Dept Urol, Urol Res Labs, Memphis, TN 38163 USA
[2] Coulston Fdn, White Sands Res Ctr, Alamogordo, NM USA
来源
JOURNAL OF UROLOGY | 1999年 / 162卷 / 04期
关键词
benign prostatic hyperplasia; aging; chimpanzee;
D O I
10.1016/S0022-5347(05)68340-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The etiology and natural history of benign prostatic hyperplasia (BPH), the most common benign disease in aging men, remain obscure. The canine BPH model has serious limitations but other animal BPH models have not been identified. We evaluated whether the chimpanzee, man's closest primate relative, developed spontaneous BPH. Materials and Methods: A cross-sectional analysis of a colony (White Sands Research Center) that contained 700 chimpanzees was undertaken by sampling 63 male and female (controls) chimpanzees 8 to 35 years old. The presence of spontaneous BPH was evaluated by assessing pathological and clinical variables, including prostate volume, serum prostate specific antigen, presence of histological BPH, serum androgens and estradiol, and urodynamics studies. Results: The chimpanzee had evidence of spontaneous histological BPH, and incidence and grade increased with age. Spontaneous BPH was manifested by increased prostate volume, higher serum prostate specific antigen, higher stromal/epithelial ratio and decreased urinary flow rates. As in man, serum androgens did not correlate with BPH in the chimpanzee. Conclusions: Male chimpanzees developed spontaneous histological BPH at the same relative point in their life cycle as humans which resulted clinically in larger prostates and decreased urinary flow rates. Serum hormone levels did not appear to correlate with BPH. A better understanding of the chimpanzee-BPH model may lead to new therapeutic strategies for BPH in man.
引用
收藏
页码:1454 / 1461
页数:8
相关论文
共 50 条
  • [21] Benign prostatic hyperplasia and urolithiasis
    Krombach P.
    Michel M.S.
    Der Urologe, 2010, 49 (Suppl 1): : 149 - 153
  • [22] PSA and benign prostatic hyperplasia
    Grall, J
    Corbel, L
    ANNALES D UROLOGIE, 2004, 38 : S43 - S45
  • [23] Prostatic stents for the treatment of benign prostatic hyperplasia
    VanderBrink, Brian A.
    Rastinehad, Ardeshir R.
    Badlani, Gopal H.
    CURRENT OPINION IN UROLOGY, 2007, 17 (01) : 1 - 6
  • [24] Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia
    Bodker, A
    Bruun, J
    Balslev, E
    Iversen, HG
    Meyhoff, HH
    Andersson, KE
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 (04): : 237 - 242
  • [25] Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia
    Sen, Volkan
    Demir, Omer
    Esen, Ahmet Adil
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 62 - 64
  • [26] Apoptotic versus proliferative activities in human benign prostatic hyperplasia
    Kyprianou, N
    Tu, HC
    Jacobs, SC
    HUMAN PATHOLOGY, 1996, 27 (07) : 668 - 675
  • [27] Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia
    T. G. Borovskaya
    S. I. Kamalova
    V. A. Grigor’eva
    M. E. Poluektova
    A. V. Vychuzhanina
    A. V. Kuchin
    I. Yu. Chukicheva
    E. V. Buravlev
    T. I. Fomina
    M. B. Plotnikov
    V. E. Goldberg
    A. M. Dygai
    Bulletin of Experimental Biology and Medicine, 2019, 167 : 606 - 609
  • [28] Effectiveness of Phenolic Antioxidants in Experimental Model of Benign Prostatic Hyperplasia
    Borovskaya, T. G.
    Kamalova, S. I.
    Grigor'eva, V. A.
    Poluektova, M. E.
    Vychuzhanina, A. V.
    Kuchin, A. V.
    Chukicheva, I. Yu.
    Buravlev, E. V.
    Fomina, T. I.
    Plotnikov, M. B.
    Goldberg, V. E.
    Dygai, A. M.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 167 (05) : 606 - 609
  • [29] Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
    Tarim, Bahar Arican
    Camur, Emre
    Kavukoglu, Ovunc
    Kosemen, Mete
    Ozgur, Yasemin
    Narter, Kamil Fehmi
    JOURNAL OF UROLOGICAL SURGERY, 2023, 10 (03): : 194 - 198
  • [30] Biomarkers for the Diagnosis of Prostatic Inflammation in Benign Prostatic Hyperplasia
    Robert, Gregoire
    Smit, Frank
    Hessels, Daphne
    Jannink, Sander
    Karthaus, Herbert F. M.
    Aalders, Tilly
    Jansen, Kees
    de la Taille, Alexandre
    Mulders, Peter F.
    Schalken, Jack A.
    PROSTATE, 2011, 71 (15): : 1701 - 1709